Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 5.86B 675M 2026-03
Bayer EUR 5.35B 1.02B 2025-09
Bio-Rad Laboratories USD 345.2M 1.8M 2025-12
EDAP TMS EUR 5.97M 850K 2025-09
J&J USD 17.24B 642M 2026-03
Mesa Laboratories USD 39.75M 4.3M 2024-12
OraSure Technologies USD 11.34M 435K 2025-12
Plus Therapeutics 1.37M 30K 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Siemens EUR 8.1B 567M 2025-09
Surmodics USD 20.08M 31.62M 2025-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tosoh JPY 67.57B 10.89B 2025-09
Trinity Biotech USD 6.47M 1.59M 2025-09
Veracyte USD 101.16M 814K 2026-03